September 8, 2022

Press Release: ECOG-ACRIN completes the first randomized phase 3 clinical trial of neoadjuvant immunotherapy in patients with kidney cancer

May 27, 2022

Press Release: ECOG-ACRIN research highlights at ASCO 2022

May 17, 2022

Media Advisory: ECOG-ACRIN data at ASCO will showcase the Group’s robust research portfolio

March 25, 2022

Press Release: Enrollment in TMIST breast cancer screening trial surpasses halfway mark; recruitment of women from diverse backgrounds is key to success

March 16, 2022

Press Release: ECOG-ACRIN opens a new NCI-MATCH treatment arm for dMMR and LAG-3-positive cancers as it continues to locate patients with BRAF mutations

December 21, 2021

Press Release: A new post-surgery approach for treating HPV-related throat cancer uses less radiation safely and spares the majority of patients from chemotherapy

November 16, 2021

Press Release: Practice-changing trial results for advanced skin cancer

November 15, 2021

Press Release: Mitchell D. Schnall re-elected as Group Co-Chair of the ECOG-ACRIN Cancer Research Group

October 6, 2021

Press Release: Chronic stress is linked to poor breast cancer outcomes

ECOG-ACRIN Cancer Research Group